| 000 | 02843nas a22002655i 4500 | ||
|---|---|---|---|
| 001 | 2730-7034 | ||
| 003 | DE-He213 | ||
| 005 | 20260610082442.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 200812s||||||||xxkuu poo|||||| b|EN |d | ||
| 022 | _a2730-7034 | ||
| 024 | 7 |
_a43682 _2local |
|
| 210 | 1 | 0 | _aEpigenetics Commun. |
| 245 | 1 | 0 |
_aEpigenetics Communications _h[electronic resource] / _cedited by Marianne Rots, Lucia Altucci. |
| 264 | 1 |
_aLondon : _bBioMed Central : _bImprint: BioMed Central. |
|
| 300 | _bonline resource. | ||
| 520 | _aEpigenetics Communications covers the broad spectrum of epigenetic science from basic research to technological, molecular and preclinical innovations, as well as their theoretical, ethical and societal dimensions. Epigenetics Communications is an open-access journal devoted to the study and problematization of epigenetic principles and mechanisms in basic and translational research settings. The editorial process of Epigenetics Communications focusses on the technical quality of the manuscript including the robustness and validity of the research, from methodological, analytical, statistical and ethical perspectives. Novelty and potential impact are not a pre-requisite for the evaluation. It is also a forum for interdisciplinary debates around epigenetics, as well as for the investigation of its societal dimensions. The journal publishes studies related to the following topics: Molecular Epigenetics (Histone Modifications; DNA Methylation; DNA Demethylation) Nuclear Organization Mitotic & Meiotic Heritability Epigenetic Drugs Epigenetic Technologies Epigenetic Bioengineering Network Epigenetics Computational Epigenomics Single Cell Epigenetics Epigenetic Toxicology Epigenetic studies using Model Organisms (Vertebrates; Invertebrates; Plants; Unicellular systems) Epigenetics, Ethics and Society Submissions describing clinical applications should first be considered for submission to the sister journal, Clinical Epigenetics. This innovative journal will also act as a forum to showcase and discuss alternative conclusions/interpretations of well-established epigenetic phenomena. These can be based either on the (re-)analyses of published and/or new data, or on the findings and results of epigenetic research in interaction with other disciplines. As such, we welcome 'systematic’ and ‘critical’ studies, be them positive (expected) or negative (non-expected) with respect to their outcomes. | ||
| 650 | 0 | _aMedical genetics. | |
| 650 | 1 | 4 | _aMedical Genetics. |
| 700 | 1 |
_aRots, Marianne. _eeditor. _4edt _4http://id.loc.gov/vocabulary/relators/edt |
|
| 700 | 1 |
_aAltucci, Lucia. _eeditor. _4edt _4http://id.loc.gov/vocabulary/relators/edt |
|
| 710 | 2 | _aSpringerLink (Online service) | |
| 856 | 4 | 0 |
_uhttps://epicom.biomedcentral.com _zOpen Access |
| 999 |
_c999 _d999 |
||